Technology Briefing Pharma and Biotech

Feb 17, 2026

The pharmaceutical and biotech industry finds itself caught between trade policy upheavals and technological revolutions: how competitive is Europe in light of this complex situation?

This blog is for members only.
You are not logged in - please log in.
Login

Blog

Related Blog Posts

Apr 25, 2025

Beyond the Screen: How Spatial Computing Is Reshaping Industry

Dassault Systèmes and Apple are bringing immersive collaboration to the enterprise. In this interview, Tom Acland, CEO of 3DEXCITE, Dassault Systèmes, explains how spatial computing enables a new kind of interaction with virtual twins – and why this marks more than just another step in digital transformation.

Apr 15, 2025

European Artificial Intelligence Act (EU AIA)

With the Artificial Intelligence Act (AIA), the European Commission has presented a draft law to regulate artificial intelligence (AI), which regulates the use of AI in research and industry based on risk categories and even prohibits it if the risk is unacceptable. The law affects providers and users of AI systems within the EU, even if they are based outside the EU, and provides for high penalties in the event of violations to strengthen protection against automated decision-making and ensure data sovereignty.

Apr 15, 2025

Why is sovereignty becoming digital?

The fourth industrial revolution, driven by AI and digital technologies, is fundamentally transforming the way we live and work, but also harbors risks such as cybercrime and dependence on digital monopolies. To minimize these risks and safeguard European values, digital sovereignty, i.e. control over one's own data and digital infrastructures, is of crucial importance for companies and states.